Nineteen recent isolates and three laboratory strains of herpes simplex virus types I and 2 were tested for their ability to produce clinical signs in mice following intradermal inoculation in the ear. All viruses produced erythema at the inoculation site; this was the most sensitive clinical sign of infection. Virus multiplication in the ear tissue was similar for both types I and 2 up to the fifth day after inoculation but type 2 viruses persisted for longer. Latent infection was demonstrated in cervical dorsal root ganglia. Type I viruses required a much higher dose than type 2 to produce neurological signs and death after intradermal inoculation but the difference was less after intracerebral inoculation.
INTRODUCTION
The mechanisms underlying latent and recurrent infection with herpes simplex virus have long been of interest to virologists. From experiments with latently infected mice (Stevens & Cook, ~97I) and observations on human trigeminal ganglia (Bastian et al. ~972; Baringer & Swoveland, I973; Rodda, Jack & White, I973) and sacral dorsal root ganglia (Baringer, I974) it is now well established that this virus can remain latent in sensory ganglia. Mice inoculated into the hind footpad have proved useful in establishing the role of these ganglia, but such mice show neither natural recurrence, nor reactivation of disease after treatment with a variety of agents (Stevens & Cook, r 973) . Further progress in studying the establishment, control and breakdown of the latent infection would be greatly aided if an experimental system was available that showed more similarity to the human disease.
This report describes the establishment of latent and recurrent infection in mice inoculated into the skin of the ear with recent isolates of herpes simplex virus. The results suggest that this model is more analogous to the human infection than those used previously. Observations are also made on the virulence for mice of recent isolates of herpes simplex virus types I and 2 (HSV~ and HSV2).
4-week-old mice. Each mouse received o-o2 ml into the right cerebral hemisphere. The LDso was calculated by the Spearman-K~irber method (Finney, 1952) from the number of mice dying between the 2nd and u8th day after inoculation.
Ear biopsy. After anaesthetizing the mouse, a sample from the area of the ear showing recurrent erythema was taken using the 1. 5 mm diam. punch of a revolving punch plier. The disc of skin was cut into quarters; one piece was tested for the presence of infectious virus, the others were stored for examination by electron microscopy, and other tests.
Assay of infectious virus in tissue samples.
When necessary, samples of ear tissue were stored whole in maintenance medium at -6o °C. After thawing, large samples were minced with scissors into fragments of I to z mm diam. These were then ground in a Griffith's tube (Jobling & Co., Ltd) in a small volume (o-2, 0"5 or 1 ml) of maintenance medium. Tenfold dilutions of the suspension were then inoculated on to confluent VERO cell cultures (2o #1/ culture) and allowed to adsorb for I h before addition of medium. When maximum sensitivity was required, samples were tested without storage. In this case, the tissue was ground in a Griffith's tube in o'z5 ml medium and the tube washed with a further o'25 ml. The suspension and washings were inoculated on to a VERO cell monolayer in a 3"5 × 8 cm plastic flask (Nunc, U.K. Ltd) or onto four cultures in tubes. When there was a large amount of tissue debris the medium was changed after 24 h incubation to reduce toxic effects from the inoculum. Co-culture of cervical dorsal root ganglia with VERO cells. Mice were killed by chloroform and the second, third and fourth cervical dorsal root ganglia were removed from the right side as quickly as possible. They were put on to monolayers of VERO cells in ' Multi-dishes' and the cultures were examined daily for three weeks for c.p.e, characteristic of HSV infection in the VERO cells. Electron microscopy. Portions of the skin biopsy samples were fixed in 1"5 ~ glutaraldehyde in cacodylate buffer at 4 °C, post-fixed in 1 ~ osmium tetroxide and embedded in Araldite. Sections were stained with lead citrate and uranyl acetate and examined in a Philips EM2oI electron microscope.
RESULTS

Survey of HSV types I and 2 by intradermal inoculation of the ear
From this survey it was hoped to choose suitable strains of HSV for use in experiments on latency. A number of recent isolates, I0 each of types 1 and 2 and three laboratory strains, two type I, one type 2, were therefore screened for their ability to produce clinical disease in mice inoculated intradermally in the ear. This site was chosen because it was hoped that superficial lesions might be recognizable in the thin and relatively hairless tissue; a further advantage was the convenience with which repeated samples could be taken by punch biopsy. Except for the laboratory strains and the isolate from encephalitis, viruses were tested without cloning after only one passage in vitro in an attempt to retain the characteristics of the virus population from the human lesion.
Preliminary experiments showed that the doses needed to give a range of clinical signs were different for type I and type 2 viruses. Except where noted otherwise, groups of 10 mice received 2 × IO 5, 2 X io 4, or 2 × 10 8 p.f.u, of type I viruses, or 2 X 10 8, 2 × 10 2, or 2 × Io 1 p.f.u, of type 2. Clinical signs were noted daily for 28 days. Following inoculation the infected ear usually became erythematous within z to 5 days; animals then either recovered without further signs, or developed signs suggestive of neurological involvement. Some mice died, survivors occasionally showed prolonged locomotor abnormality or ear paralysis. Erythema, neurological signs and mortality are considered in detail below. Erythema was clearly visible as a reddening of the whole or part of the pinna. The proportion of mice in which erythema developed and the time of its first appearance depended on dose (Table I ) but, with one exception (ARI i) there were no clear differences in ability to produce erythema between individual viruses or types I and 2. The type 2 isolate ARI I produced the least erythema of all viruses; only at a dose of 2 × IO 5 p.f.u./mouse did half the mice show erythema. Erythema of the ear was the most sensitive clinical indication of disease. The duration of erythema was variable (usually between I and I6 days) but it had commonly disappeared by the 21st day after inoculation. In 4 ~ of mice that survived after showing clinical signs, however, erythema reappeared during the 4th week after inoculation.
Surface ulceration visible to the naked eye was seen in IO to 5o ~ of mice depending on virus, particularly with a dose of 2 × 105 p.f.u./mouse. It usually developed between I and 3 weeks after inoculation and remained visible for I to 7 days.
Preliminary histological examination of infected ears showed that both types of virus produced tissue damage characteristic of herpes infection of the skin, viz. engorgement of blood vessels and cellular infiltration, predominantly of polymorphonuclear leucocytes in the dermis, and necrosis of epidermal cells (some of which contained eosinophilic inclusion bodies) leading to vesiculation and scab formation.
There were clear differences between viruses of type ~ and type 2 in the dose required to produce overt neurological disease. These signs were seen in almost all mice that died (Table 2) . They usually appeared I to 6 days after the onset of erythema and were sometimes present for only a single day before death.
In mice that died, paralysis of the right forelimb was the most common sign of neurological disease though the hind limbs were quite often affected. The inoculated ear and side of the face were also frequently paralysed. The pathology underlying ear paralysis was not studied and it is not known whether this paralysis resulted from damage in the nervous system. In a few animals other signs occurred; they included disorientation, circling, excessive salivation, inflammation around the eyes and compulsive scratching of the inoculated ear. There were no major differences in the clinical signs that preceded death after inoculation with different isolates or types of virus, but the small number of deaths caused by type 1 viruses precluded detailed analysis.
A much greater number of animals survived infection with type I viruses than with type 2 after showing signs of nervous system involvement. There were 35 such survivors compared with a total of 4o deaths from infection with type I ; all these survivors showed ear paralysis, 4 showed limb paralysis. The comparative figures for type 2 infections were 12 survivors and 98 deaths; of these survivors 5 showed ear paralysis and 7 limb paralysis. In mice that survived infection with type 2 viruses signs of neurological involvement appeared later (mean I4"~ days after inoculation) than in mice that survived infection with type I (mean 8-6 days). The time of onset of these signs showed no significant variation over the range of doses tested for either type of virus.
There were also differences in the pattern of mortality produced by type I viruses compared with the majority of those of type 2 (Table 3 ). Since our prime interest was in latency and recurrent disease in surviving mice the range of doses was chosen to show the spectrum of clinical signs rather than high mortality, and even at the highest of these doses many isolates killed less than 5o ~o of the mice. Moreover, several had very shallow dose response curves. The LDso values were therefore not calculated.
The type I viruses were generally of low virulence; 6 of the i2 killed animals only sporadically over the range of doses tested. The virus isolated from a case of encephalitis (SC55/Br) resembled the more virulent of the group whereas the laboratory strain (HSVI/Lab.) and that received from Dr Planterose (HSVI/P1), which had been selected for its ability to produce local lesions in hairless mice, were among the less virulent.
With the exception of one isolate (ARI I) the type 2 viruses were of much greater virulence, indeed the figures suggest a factor of at least ioo-fold greater as compared with type I. The laboratory strain (HSV2/Lab.) was of relatively low virulence. The isolate ARI I was amongst the least virulent of all viruses of either type. When inoculated at 2 × IO 5 p.f.u./ mouse (equal to the highest dose tested for type I) it failed to kill any animals, even though by the other criteria tested (see Methods) it was clearly a type 2 virus.
Multiplication of virus at the inoculation site
To test whether differences in pathogenicity after intradermal inoculation were related to differences in multiplication at the inoculation site, the titre of infectious virus in the whole pinna was measured at intervals after inoculation. Two isolates each of type I and 2 were used. At the dose chosen (2 × IO 3 p.f.u./mouse) the type I isolates SCI6 and SC22 killed few mice, but those of type 2 (AR6, AR7) killed about 50 ~ of the group.
With all four isolates similar amounts of virus were found early in the infection; the highest titres (about IO 4 p.f.u./ear) occurred on the 5th day after inoculation. Thereafter the amounts of virus decreased and by the ninth day none was found in the ears of mice inoculated with the type I isolates (Table 4) -Infectious virus was, however, still present in 6 of the 7 mice that survived inoculation with isolate ART and in 3 of the 5 survivors with AR6. Even after I2 days the ear of one mouse inoculated with AR7 still contained virus. A second experiment using a Ioo-fold higher dose of 8C22 confirmed the difference in the time for which infectious virus of isolates SC22 and AR6 remained in the ear tissue (Table 4) .
In a further similar experiment groups of 15 mice were tested at intervals up to I month after inoculation with 2 × IO 5 p.f.u./mouse of the type I isolate SCI6 (Table 4 ). In the same mice the incidence of infection in the dorsal root ganglia was also studied. Dissection showed that the ear innervation involves the second, third and fourth cervical dorsal root ganglia as well as the facial and trigeminal ganglia. Examinations were limited to the three cervical ganglia. On the I4th, 2Ist and 28th day after inoculation these ganglia were removed and co-cultivated with VERO cells. Infectious virus was isolated from the ear tissue of only one of the mice tested more than 7 days after inoculation but HSV was isolated from the dorsal root ganglia of 32/45 of these animals. Viral c.p.e, was first seen in the VERO cells 7 to 2I days after the cultures were set up.
Intracerebral inoculation of mice
It was hoped that intracerebral (i.c.) inoculation of selected HSVI and HSV2 would heIp to distinguish the effects of host defence mechanisms in the central nervous system (c.n.s.) from those in the skin of the ear. The type I viruses tested were SCI6, 8C22 (respectively the most and least pathogenic by inoculation in the ear) and SC55/Br. Those of type 2 were AR6, AR7 and A R I r , the first two of which were chosen as representative of the group; A R I I produced disease in very few mice after intradermal injection. All the viruses killed more mice by intracerebral inoculation than by the intradermal route (Table 5) . However, the difference between the types was much less pronounced; isolate A R I I was again the least pathogenic of either type. With isolate SC22 the range of doses over which a similar proportion of animals died was so large that the LDs0 could not be calculated. • 4/I I * Number of mice that showed clinical signs in first 2 weeks after inoculation. 7 of these had z recurrences. + Not done.
Recurrence of infection in the ear
Reappearance of erythema in the ear, after mice had recovered from all clinical signs, suggested the possibility that some disease process was recurring at the inoculation site. The sporadic incidence and the range of isolates over which the phenomenon was seen left no obvious choice of virus for further investigation. It was felt that production of neurological signs might reflect more extensive infection of the nervous system and thereby a greater incidence of latent infection, but type 2 viruses were not suitable because few mice survived after showing such signs. The type 1 isolate, SC16, was therefore used because it produced a significant number of mice with recurrent erythema and the largest number of survivors with neurological signs (including ear paralysis).
SCI6 was inoculated intradermally into the right ear of 6o female mice at a dose of 2 x io 4 p.f.u./mouse. The animals were examined daily for a total of 15o days. When erythema recurred in the inoculated ear, a biopsy sample was investigated and the mouse was returned to the group for further observation. During the first 2 weeks after inoculation 4o of the mice showed erythema of the ear and of these three had overt paralysis. After the primary clinical signs had subsided, 21 mice showed recurrence of erythema in the inoculated ear (Table 6 ) and in seven it recurred twice. With one exception all recurrences were in mice which had shown erythema during the first 2 weeks after inoculation. The recurrent erythema was often confined to a discrete area of about ~ to ½ of the pinna. Herpes simplex virus with plaque morphology characteristic of type I was isolated from seven of the 25 samples tested for infectivity; the amount of virus present in the tissue varied widely, from ~ to Iooo p.f.u./ sample. Oae of the isolated viruses was confirmed serologically as type I by the Public Health Laboratory, Bristol.
The three biopsy samples with the highest levels of infectious virus were chosen for detailed examination by electron microscopy. Herpes virus lesions were detected in two of these, taken at 99 and Ioo days after inoculation. Infected cells containing mature enveloped Fig. I . Basal epidermal cell from a recurrent lesion on the 99th day after inoculation. N, naked virus particle in nucleus; E, enveloped particle in cytoplasm; T, bundles of tonofilaments; B, basement membrane; C, collagen in dermis. virus were found in the basal layers of the epidermis (Fig. I ) and in some areas there were many enveloped particles in the intercellular spaces (Fig. 2) . There was evidence of vesicle formation in the upper layers of the epidermis and in these areas the infected cells were very degenerate. There was no morphological evidence of virus infection in dermal cells but there was a moderate infiltration of inflammatory cells, predominantly polymorphonuclear leucocytes. In a second, similar experiment with a bigger dose (2 x lO 5 p.f.u./mouse) 25 of the 62 inoculated mice died, all of the survivors showed erythema of the ear and all but five of these had ear paralysis. During the Io 9 days of observation 17 mice showed recurrence of erythema (Table 6 ). When this developed the mouse was killed and the whole pinna was either tested for infectious virus or stored for histological examination. In addition, from eight of these mice the 2nd, 3rd and 4th cervical dorsal root ganglia were tested for infectious virus by grinding the tissue and inoculating the suspension on to VERO cell cultures. Herpes simplex virus was isolated from only one ganglion.
DISCUSSION
It is well established that the differences between HSVI and HSV2 include the greater virulence of type 2 viruses for laboratory animals (Nahmias & Dowdle, 1968; Figueroa & Rawls, I969; Plummer et al. i97o) , and the present study confirms this in young adult mice. When inoculated intradermally type I viruses were about IOO times less pathogenic than type 2. However, intracerebral inoculation resulted in an increase in pathogenicity of IOOOO-fold for type I and IOOO-fold for type 2. Thus type I viruses were about Io-fold less virulent than type 2 following intracerebral inoculation. These complex relationships probably arise from the complexity of the disease process itself which allows the possibility of partial or complete control by the host at various stages. These include multiplication of virus in the skin, ingress into the nervous system and spread through this tissue with resulting damage to cells at each stage.
The difference in virulence between types I and 2 is unlikely to result from multiplication at the inoculation site since both virus types multiplied to similar titres. However, the greater persistence of type 2 viruses in the skin prolongs the time over which virus could enter the nervous system and this might explain their greater virulence. The persistence might also explain the late onset of neurological signs in some mice inoculated with type 2 viruses and suggests that defence mechanisms in the local tissue might control type 2 infections less effectively than those of type I. Since macrophages play a decisive part in limiting HSVI infections in mice (Hirsch, Zisman & Allison, I97O) their activity against the two types of virus is being studied.
Neurotropic herpes viruses travel from a peripheral inoculation site to the c.n.s, by way of nerves, probably by intra-axonal flow (Cook & Stevens, 1973; Kristensson & Olsson, 1973; McCracken, McFerran & Dow, 1973; Field & Hill, 1974 , 1975 . However, nothing is known about the extent or rate of uptake of herpes viruses into nerves, though differences in these respects could affect neurovirulence.
The fact that most mice infected with type 2 viruses died if they showed neurological signs suggests that once these viruses reach the c.n.s, the defence mechanisms are unable to stop their spread. The few survivors from type 2 infections almost all developed neurological signs late in the primary disease, so that it is likely that there was time for an immune response to develop before the virus reached the c.n.s. In contrast many mice infected with type I viruses showed only ear paralysis and most of these survived, which suggests a more effective control of the infection. The high incidence of latent infection of dorsal root ganglia by HSVI shows that these viruses frequently reach at least this part of the nervous system without apparent permanent harm to the mouse.
The response to infection of different neural cell types clearly might affect the spread of virus and damage in the nervous system. Neurons are known to support productive replication of HSV whereas in glial cells replication is defective (Dillard, Cheatham & Moses, 1972; Cook & Stevens, I973; Hill & Field, I973) and the two cell types show a similar pattern in their reaction to pseudorabies (Becker, I968; McCracken et al. I973; Field & Hill, I974) and rabies and related viruses (Murphy et al. I973) . The greater invasiveness of HSV2 compared with HSVI could therefore result from differences in their ability to induce productive infection in glial cells; a subject that is now being investigated.
When some of the isolates were inoculated intradermally mice were killed over a very wide range of doses. Since individual clones of the isolates were not selected these flat doseresponse curves may have arisen from interactions between virulent and avirulent viruses in the inoculum, as can happen with Semliki Forest virus (Bradish, Allner & Maber, I972) . Study of clones of virus from human infections might therefore be valuable in assessing the significance of different viral populations in human disease.
The results from some of the individual isolates deserve comment. The one from encephalitis (SC/55Br) was typical of type I ; in particular it showed no enhanced neurovirulence. However, a more extensive survey of the comparative virulence of such isolates would be valuable. The laboratory strains, although less virulent than most of the freshly isolated viruses, showed the characteristic difference between the types which suggests that virulence markers are relatively unaffected by a few passages in culture. As yet we have no explanation for the extreme avirulence of ARt I, but the virus may prove useful in future comparative studies.
Judged by the disappearance of erythema, lesions in the skin, or infectious virus, the primary disease in the ear tissue was finished 2 to 3 weeks after inoculation. Mice infected with HSVI then had latent infection in the cervical dorsal root ganglia, which confirms the original report by Stevens & Cook (I97 I) of latent infection in lumbo-sacral ganglia of mice inoculated into the footpad and the recent work of Walz, Price & Notkins (I974) showing latency in lumbo-sacral and trigeminal ganglia. Thus it seems likely that latent infection can be established in any sensory ganglion depending on the site of inoculation.
An important new finding was that active infection recurred with erythema at the inoculation site. Such spontaneous recurrent disease in mice has not previously been reported, perhaps because a degree of erythema easily seen in the ear might be difficult to see in the more cornified tissue of the footpad. The sequence of events in the ganglion and skin during recurrent disease is clearly important, particularly since our results suggest that infectious virus was often absent from the ganglia when recurrent erythema developed in the skin. By contrast, J. G. Stevens (personal communication) and Walz et al. (i 974) used the isolation of infectious virus from ganglia to define reactivation in the absence of recurrent skin lesions.
Recurrent cutaneous herpes lesions have been reported in hairless mice passively immunized at the time of original infection and subsequently treated with corticosteroids (Underwood & Weed, I974), but in a careful study using normal mice, Stevens & Cook (I973) failed to provoke recurrent disease. In the rabbit, recurrent herpetic infection gave encephalitis (Good & Campbell, i948; Schmidt & Rasmussen, I96o) or ocular disease (Anderson, Magruder & Kilbourne, I96I ; Laibson & Kibrick, I966) . However, infection in the mouse ear has major advantages of cost, convenience of observation and sampling, and ease of manipulation of the animal's immunological responses. It also closely resembles the human disease in that primary and recurrent infection are in the skin, repeated recurrences develop spontaneously and the associated latent infection in the ganglia occurs in the absence of overt neurological disease (see also McKendal, Vogelzang & Jackson, I974). In conclusion, the characteristics of HSV infection in the mouse ear make it a valuable new model for latency and recurrent infections in humans.
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